Tradename: ERVEBO
Proper Name: Ebola Zaire Vaccine, Live
Indication: To extend the indication for use to include individuals 12 months of age and older.
ERVEBO is a vaccine indicated for For the prevention of disease caused by Zaire ebolavirus in individuals 12 months of age and older.
Approval Date: 07/27/2023
Manufacturer: Merck Sharp & Dohme LLC
More: https://www.fda.gov/vaccines-blood-biologics/ervebo